Occult breast carcinoma presenting as axillary metastases

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 1, 2000, Pages 143-147

  Foroudi, Farshad ^a   Tiver, Kenneth W ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Axillary lymphadenopathy; Breast neoplasm; Occult primary; Radiotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAMMOGRAPHY; MASTECTOMY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL RATE; ULTRASOUND;

ADENOCARCINOMA; ADULT; AGED; AXILLA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0034177229     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00542-8     Document Type: Article

References (28)

1. Halsted W.S. The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 46:1907;1-19.
2. Tench D.W., Page D.L. The unknown primary presenting with axillary lymphadenopathy. Bland K.I., Copeland E.M. 2nd ed. The breast Comprehensive management of benign and malignant diseases . Vol. 2:1998;1447-1452 W.B. Saunders, Philadelphia.
3. Van Ooijen B., Bontenbal M., Henzen-Logmans S.C., et al. Axillary nodal metastases from an occult primary consistent with breast carcinoma. Br J Surg. 80:1993;1299-1300.
4. Jackson B., Scott-Conner C., Moulder J. Axillary metastases from occult breast carcinoma Diagnosis and management . Am Surg. 61:1995;431-434.
5. Ellerbroek N., Holmes F., Singletary W., et al. Treatment of patients with isolated nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer. 66:1990;1461-1467.
6. Campana F., Fourquet A., Ashby M.A., et al. Presentation of axillary lymphadenopathy without detectable breast primary (T0N1b breast cancer) Experience at Institut Curie . Rad Oncol. 15:1989;321-325.
7. Whillis D., Brown P.W., Rodger A. Adenocarcinoma from an unknown primary presenting in women with an axillary mass. Clin Oncol (RCR). 2:1990;189-192.
8. Vilcoq J.R., Calle R., Ferme F., Veith F. Conservative treatment of axillary adenopathy due to probable subclinical breast cancer. Arch Surg. 117:1982;1136-1138.
9. Read N.E., Strom E.A., McNeese M.D. Carcinoma in axillary nodes in women with unknown primary site Results of breast-conserving therapy . Breast J. 2:1996;403-409.
10. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 337:1997;956-962.
11. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 337:1997;949-955.
12. Ahern V., Barraclough B., Bosch C., et al. Locally advanced breast cancer Defining an optimum treatment regimen . Int J Radiat Oncol Biol Phys. 28:1994;867-875.
13. Leibman A.J., Kossoff M.B. Mammography in women with axillary lymphadenopathy and normal breasts on physical examination Value in detecting occult breast carcinoma . AJR. 159:1992;493-495.
14. Coons T.A. MRI's role in assessing and managing breast disease. Radiol Technol. 67:1996;311-336.
15. Morris E.A., Schwartz L.H., Dershaw D.D., et al. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology. 205:1997;437-440.
16. Tilanus-Linthorst M.M., Obdeijn A.I., et al. MRI in patients with axillary metastases of occult breast carcinoma. Breast Cancer Res Treat. 44:1997;179-182.
17. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen Danish Breast Cancer Cooperative Group DBCG 82c randomised trial . Lancet. 353:1999;1641-1648.
18. Zissiadis Y., Langlands A.O., Barraclough B., et al. Breast conservation Long-term results from Westmead Hospital . Aust N Z J Surg. 67:1997;313-319.
19. Fisher B., Anderson S., Redmond C.K., et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 333:1995;1456-1461.
20. Merson M., Andreola S., Galimberti V., et al. Breast carcinoma presenting as axillary metastases without evidence of a primary tumor. Cancer. 70:1992;504-508.
21. Baron P.L., Moore M.P., Kinne D.W., et al. Occult breast cancer presenting with axillary metastases. Arch Surg. 125:1990;210-215.
22. Vezzoni P., Balestrazzi A., Bignami P., et al. Axillary lymph node metastases from occult carcinoma of the breast. Tumori. 65:1979;87-91.
23. Kemeny M.M., Rivera D.E., Terz J.J., et al. Occult primary adenocarcinoma with axillary metastases. Am J Surg. 152:1986;43-47.
24. Iglehart J.D., Ferguson B.J., Shingleton W.W., et al. An ultrastructural analysis of breast carcinoma presenting as isolated axillary adenopathy. Ann Surg. 196:1982;8-13.
25. Carter C.L., Allen C., Henson D.E. Relation of tumor size, lymph node status and survival in 24,470 breast cancer cases. Cancer. 63:1989;181-187.
26. Silverstein M.J. Predicting axillary nodal positivity in 1,787 patients with invasive breast carcinoma. Breast J. 4:1998;324-329.
27. Patel J., Nemoto T., Rosner D., et al. Axillary lymph node metastasis from an occult breast cancer. Cancer. 47:1981;2923-2927.
28. Treatment of early-stage breast cancer. NIH Consensus Statement Online, 1990 Jun 18-21 [cited 1999/4/15]; 8:1-19.